FONU START OF BETA TESTING WAVE 1/FONU2 Announces the Start

New Post Public Reply Private Reply Replies (1) Message Board
Compensated Post
shakerzzz
FONU >>START OF BETA TESTING WAVE 1/FONU2 Announces the Start of Beta Testing Wave 1

FORT LAUDERDALE, FL--(Marketwired - Jan 22, 2014) - FONU2 (OTCBB: FONU) (OTCQB: FONU) announced today that Beta testing had commenced on its social commerce platform.

Last Friday, FONU2 announced that they had finished the development of the core functionality for their social commerce web-site and had successfully completed the Alpha testing phase. The Beta Testing phase is expected to run for the next 6 to 8 weeks leading the way to a full public launch.

Yesterday, FONU2 sent out invitations to the first wave of Beta Testers along with testing instruction and a quick reference guide. Beta Testers are expected to sign-up, create a business profile, test drive the core function of the application, and report any bugs they encounter. Beta Testers are also encouraged to provide ideas on how to improve the functionality of the system and the user experience. Each week FONU2 will be inviting additional groups of testers until the Beta is successfully completed.

It's still not too late to get in on the action by signing up to be a FONU2 beta-tester and you can earn incentives and major discounts as well. Visit the FONU2 Beta-Tester Sign-Up Page to learn more and begin the registration process.

About FONU2 Inc.:
FONU2 is a social commerce company that provides a precision mobile sales and marketing platform that functions like an order reservations and booking system. Members via their mobile phones and computers list, buy, sell, and trade services and items locally in any neighborhood, anywhere in the world. Transactions are paid with the FONU2 end-to-end mobile phone payment card system. For additional information, visit our website, www.FONU2.com. You can also follow us on our social network, Facebook, Google + and Twitter.

This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact:

Investor Relations
Mark Kabbash
EquityGroups
646.408.2661
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 32

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 41

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 20

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 80

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 237

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Novotech Unveils Insights on Triple-Negative Breast Cancer Trials

Updated Category News Views 148

Insights into Triple-Negative Breast Cancer Clinical Trials Novotech, a global leader in full-service clinical Contract Research Organization (CRO), has published a significant report studying the global landscape of clinical trials and drug development for Triple-Negative Breast Cancer (TNBC). This comprehensive document sheds light on major advancements in therapeutic...

Continue Reading
Direct Digital's Bold Exit: Delists from Nasdaq

Updated Category News Views 32

Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...

Continue Reading
Analyzing KULR Technology Group's Rising Short Interest Trends

Updated Category News Views 552

KULR Technology Group's Short Interest Overview KULR Technology Group's (NYSE: KULR) short percent of float has seen a notable rise of 27.11% since the last report. Recent disclosures indicate that there are approximately 18.31 million shares sold short, equating to about 8.44% of all regular shares currently available for trading. Given the volume at which KULR trades,...

Continue Reading
Cantaloupe, Inc. Introduces Next-Gen Smart Store Solutions

Updated Category News Views 291

Revolutionizing Retail with Smart Store Technology Cantaloupe, Inc. (Nasdaq: CTLP), recognized globally for its cutting-edge technology solutions in self-service commerce, has recently unveiled its innovative Smart Store Series. This pioneering series includes the Cantaloupe Smart Store 600 and 700 models, which aim to transform the retail landscape for food and beverage...

Continue Reading
New Leadership Boosts Compass Lexecon's Antitrust Division

Updated Category News Views 176

Strategic Growth at Compass Lexecon Compass Lexecon, a key player in economic consulting, recently announced the significant appointments of Dr. Jeremy Verlinda as Executive Vice President and Mr. Ahsan Kirmani as Senior Vice President. This move is a testament to the firm's commitment to expanding its expertise, particularly in antitrust and financial consulting. New...

Continue Reading